Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
PUT
United States Natural Gas Fund
UNG
$497M
| $11.4M | 0.01% |
168,425
+118,425
| +237% | +$9.18M |
|
|
GBT
1302
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $11.3M | 0.01% |
142,599
+109,179
| +327% | +$6.47M |
|
1303
CALL
W.W. Grainger
GWW
$61.1B
| $11.3M | 0.01% |
33,400
-5,500
| -14% | -$1.75M |
|
|
CLR
1304
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $11.3M | 0.01% |
329,127
+257
| +0.1% | +$7.97K |
|
1305
PUT
Northrop Grumman
NOC
$82.1B
| $11.3M | 0.01% |
32,800
+3,100
| +10% | +$1.09M |
|
1306
iShares Core S&P 500 ETF
IVV
$904B
| $11.2M | 0.01% |
34,785
| – | – |
|
1307
GATX Corp
GATX
$6.23B
| $11.2M | 0.01% |
135,474
+40,841
| +43% | +$3.29M |
|
1308
Alerian MLP ETF
AMLP
$13.3B
| $11.2M | 0.01% |
263,380
-631,018
| -71% | -$26.5M |
|
1309
CALL
KKR & Co
KKR
$93.2B
| $11.2M | 0.01% |
383,700
+30,400
| +9% | +$866K |
|
1310
PUT
TechnipFMC
FTI
$29.1B
| $11.2M | 0.01% |
700,090
+676,839
| +2,911% | +$10.5M |
|
1311
Alcoa
AA
$13.6B
| $11.2M | 0.01% |
519,144
-239,025
| -32% | -$4.95M |
|
1312
PUT
CF Industries
CF
$18.4B
| $11.1M | 0.01% |
233,300
+2,600
| +1% | +$122K |
|
1313
CALL
Inspire Medical Systems
INSP
$1.73B
| $11.1M | 0.01% |
150,000
-334,800
| -69% | -$21.5M |
|
|
QVCGA
1314
DELISTED
QVC Group Inc Series A
QVCGA
| $11.1M | 0.01% |
27,182
+13,243
| +95% | +$5.97M |
|
|
PRAH
1315
DELISTED
PRA Health Sciences, Inc.
PRAH
| $11.1M | 0.01% |
100,000
+42,715
| +75% | +$4.39M |
|
|
VNET
1316
VNET Group
VNET
$2.13B
| $11.1M | 0.01% |
1,532,503
-321,383
| -17% | -$2.44M |
|
|
FLIR
1317
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $11.1M | 0.01% |
213,306
+34,388
| +19% | +$1.82M |
|
1318
Insmed
INSM
$29.4B
| $11.1M | 0.01% |
464,740
+395,409
| +570% | +$8.04M |
|
|
SCHW
1319
PUT
Charles Schwab
SCHW
$188B
| $11.1M | 0.01% |
233,300
+97,000
| +71% | +$4.28M |
|
1320
PUT
Royal Caribbean
RCL
$82.4B
| $11.1M | 0.01% |
83,100
+49,800
| +150% | +$5.8M |
|
1321
AerCap
AER
$23.5B
| $11M | 0.01% |
179,701
+73,532
| +69% | +$4.32M |
|
1322
Monolithic Power Systems
MPWR
$67.9B
| $11M | 0.01% |
62,035
+37,112
| +149% | +$5.93M |
|
1323
PUT
Fidelity National Information Services
FIS
$21.9B
| $11M | 0.01% |
79,380
+67,856
| +589% | +$9.1M |
|
|
JWN
1324
DELISTED
Nordstrom
JWN
| $11M | 0.01% |
269,421
+42,082
| +19% | +$1.56M |
|
|
AZPN
1325
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $11M | 0.01% |
91,195
-27,811
| -23% | -$3.36M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.